| Date | Title | Description |
| 21.03.2026 | Biotech Powerhouse Mestag Therapeutics Secures $40M for Advanced Therapies | Mestag Therapeutics has secured $40 million in new financing. This pushes its total funding past $95 million. The Cambridge-based biotech fuels its Phase 1 STARLYS clinical trial for cancer drug MST-0312. This pivotal trial begins in mid-20... |
| 17.03.2026 | Mestag Therapeutics Raises $40M in Financing | Mestag Therapeutics, a Cambridge, UK-based biotech company harnessing fibroblast immunology to develop treatments for cancer and inflammatory diseases, closed a $40m financing.
Backers includwed SV Health Investors, Johnson & Johnson, t... |
| 17.03.2026 | Mestag Therapeutics: $40 Million Raised To Advance Fibroblast Immunology Cancer Therapies Into Clinic | Mestag Therapeutics, a biotech company focused on fibroblast immunology, has announced the closing of a $40 million financing round, bringing its total funding to more than $95 million. The round was backed by SV Health Investors, Johnson &... |
| 13.01.2026 | VieCure Accelerates AI Precision Oncology with $43 Million Infusion | VieCure secures $43 million. Its AI-powered Halo Intelligence platform is poised to transform community cancer care. This funding addresses critical operational complexities in clinics, which serve most U.S. cancer patients. The platform bo... |
| 12.01.2026 | VieCure Raises $43M in Funding | VieCure, a Denver, CO-based provider of software platforms for oncology care, raised $43M in funding.
The round was led by Mitch Rales, and Northpond Ventures, with participation from Durable Capital Partners, Socium Ventures and Sator Grov... |
| 12.01.2026 | VieCure: $43 Million Raised To Expand AI-Powered Precision Cancer Care In Community Practices | VieCure announced it has raised $43 million to accelerate the rollout of its software platform designed to help community oncology clinics deliver precision-medicine care with greater speed and consistency.
The financing was led by Mitch Ra... |
| 11.01.2026 | Vizgen Secures $48 Million to Accelerate Spatial Multi-Omics Expansion | Vizgen, a spatial multi-omics pioneer, secured $48 million. This financing is substantial. It marks a pivotal moment for the Waltham, Massachusetts-based company. The capital fuels aggressive global expansion. It scales vital manufacturing ... |
| 10.01.2026 | Vizgen: $48 Million Funding Raised To Scale Spatial Multi-Omics Platform | Vizgen, a spatial multi-omics company, announced it has closed a $48 million financing led by ARCH Venture Partners and co-led by M Ventures and Northpond Ventures, with participation from existing investors.
Vizgen said the proceeds will s... |
| 08.01.2026 | Vizgen Raises $48M in Funding | Vizgen, a Waltham, MA-based spatial multi-omics company, raised $48M in funding.
The round was led by ARCH Venture Partners and M Ventures and Northpond Ventures with participation from existing investors.
The company intends to use the fun... |
| 16.12.2025 | Culture Biosciences Closes Series C Funding | Culture Biosciences, a San Francisco, CA-based company which specializes in cloud-based biomanufacturing, raised an undisclosed amount in Series C funding.
Backers included Northpond Ventures, Synthesis Capital, S32, and Cultivian Sandbox.
... |
| 11.09.2025 | Octave Bioscience Secures Major Funding for Precision Neurology Advancement | Octave Bioscience secured $51.1 million in fresh capital. This includes a $35.6 million Series C equity round and a $15.5 million debt facility. Funds accelerate MSDA test commercialization. This blood-based diagnostic tool measures Multipl... |
| 10.09.2025 | Octave Bioscience: $35 Million Raised For Advancing Precision Care For Neurological Diseases | Octave Bioscience, a company focused on precision medicine for neurodegenerative conditions, has announced the successful close of a $35.6 million Series C equity financing round. In addition to this funding, the company has secured a $15.5... |
| 05.09.2025 | Octave Bioscience Raises $35M in Series C Financing | Octave Bioscience, a Menlo Park, CA-based commercial stage precision care company, announced the close of its $35.6M Series C equity financing and that it has entered into a $15.5M non-dilutive term loan agreement with Silicon Valley Bank (... |
| 01.06.2025 | Outcomes4Me: Pioneering the Future of Cancer Care with AI Innovation | In the ever-evolving landscape of healthcare, Outcomes4Me stands as a beacon of hope for cancer patients. The Boston-based company recently secured $21 million in funding, a significant boost that will accelerate its mission to transform ca... |
| 31.05.2025 | Outcomes4Me: $21 Million Secured For Advancing AI-Based Cancer Care Innovation | Outcomes4Me – a developer of the leading direct-to-patient and AI-based platform transforming the cancer care experience – announced the closing of a $21 million funding round. With this round, Outcomes4Me welcomes a new investor, London-ba... |
| 30.05.2025 | Outcomes4Me Secures $21Million in Funding to Accelerate AI-Driven Innovation and Drive Global Expansion to Transform Cancer Care | Outcomes4Me Inc., the developer of the leading direct-to-patient, AI-driven platform transforming the cancer care experience, today announced the close of a $21M funding round.
“AI will reshape cancer care, and this investment accelerates o... |
| 19.03.2025 | Telesis Bio: $21 Million Raised For Accelerating Adoption Of Gibson SOLA Technology | Telesis Bio, a provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, announced that it has entered into a convertible preferred stock purchase agreement to sell ... |
| 13.03.2025 | Garuda Therapeutics Secures $50 Million to Revolutionize Blood Stem Cell Treatments | In the world of biotechnology, innovation is the lifeblood. Garuda Therapeutics, a company based in Cambridge, Massachusetts, has just taken a bold step forward. They’ve secured $50 million in Series A-1 funding. This financial boost is not... |
| 12.03.2025 | Garuda Therapeutics: $50 Million (Series A-1) Secured For Advancing Blood Stem Cell Therapies | Garuda Therapeutics – a biotechnology company creating off-the-shelf and HSC therapies for a multitude of blood disorders – announced the completion of an approximately $50 million Series A-1 funding round. Investors included OrbiMed, North... |
| 24.10.2024 | The Future of Healthcare AI: Standardization and Innovation | In the ever-evolving landscape of healthcare, artificial intelligence (AI) is a double-edged sword. It promises groundbreaking advancements but also poses significant challenges. The recent developments from Gesund.ai highlight a crucial st... |
| 21.10.2024 | HLTH: Gesund.ai’s Open-Source Library Aims to Standardize AI Validation in Healthcare | What You Should Know:
– Gesund.ai, the clinical AI validation company, today announced the open sourcing of a comprehensive library of evaluation methodologies and frameworks to help developers and users address AI performance and potential... |
| 14.10.2024 | The Shifting Sands of Venture Capital: A New Focus on Health and Senior Care | In the ever-evolving landscape of venture capital, a seismic shift is underway. Traditional tech investments are giving way to a new focus on health and senior care. This change is not just a trend; it’s a response to market realities. As v... |
| 14.10.2024 | Eleanor Health: $30 Million (Series D) Raised For Transforming Delivery Of Substance Disorder Care | Eleanor Health – an outpatient addiction treatment provider working to transform the quality, delivery and accessibility of substance use disorder care – announced it raised a $30 million Series D funding round led by General Catalyst, with... |
| 08.10.2024 | Navigating the Future of Oncology and Healthcare Production Amidst Challenges | In the world of healthcare, innovation is the lifeblood. Companies like VieCure and Fresenius are at the forefront, pushing boundaries and adapting to challenges. VieCure, with its recent $45 million funding, is revolutionizing community on... |
| 03.10.2024 | VieCure Secures 45M for AI-Enabled Community Oncology Care Platform | What You Should Know:
– VieCure Inc., pioneer of next-generation intelligence platforms that democratize community oncology care, today announced the completion of a $45 million financing led by Northpond Ventures and the appointment of ind... |
| 16.09.2024 | Inflammatix: Molecular Diagnostics Company Closes $57 Million In Funding (Series E) | Molecular diagnostics company Inflammatix announced it raised $57 million in Series E funding led by Khosla Ventures and Think.Health. This funding round will support regulatory filing and early commercialization of the company’s lead produ... |
| 12.09.2024 | Inflammatix Raises $57M in Series E Funding | Inflammatix, a Sunnyvale, CA-based molecular diagnostics company, closed a $57m Series E financing.
The round was led by Khosla Ventures and Think.Health, with participation from Northpond Ventures, D1 Capital Partners, Iberis Capital, Vesa... |
| 07.12.2022 | BREAKING: Sound Agriculture lands $75m to expand nitrogen enhancing product overseas | US-based Sound Agriculture has raised a $75 million Series D to expand its crop nutrient and plant breeding businesses. New investors BMO Impact Investment Fund and Chan Zuckerberg Initiative led the round. FootPrint Coalition and returning... |
| 19.01.2022 | Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform | Funds will allow for a rapid transition through pre-commercialization to market launch.
London, UK and Woodcliff Lake, NJ – Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces it has sec... |
| 19.01.2022 | Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform | Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform
19-01-2022
Funds will allow for a rapid transition through pre-commercialization to market launch.
London, UK and Woo... |
| 19.08.2021 | Sound Agriculture closes $45m late stage round led by Leaps by Bayer | Sound Agriculture, the self-described “bio-inspired” crop inputs company, has raised $45 million in a Series C-extension round led by Bayer‘s investment arm Leaps by Bayer. Life sciences investor Northpond Ventures also joined the round as ... |
| 19.08.2021 | BREAKING: Sound Agriculture closes $45m late stage round led by Leaps by Bayer | Sound Agriculture, the self-described “bio-inspired” crop inputs company, has raised $45 million in a Series D round led by Bayer‘s investment arm Leaps by Bayer. Life sciences investor Northpond Ventures also joined the round as a new back... |
| 19.08.2021 | Sound Agriculture closes $45m late stage round | Sound Agriculture, the self-described “bio-inspired” crop inputs company, has raised $45 million in a Series C-extension round led by Bayer‘s investment arm Leaps by Bayer. Life sciences investor Northpond Ventures also joined the round as ... |
| 28.07.2021 | Цифровая терапия — фокус на результат, а не на технологию: инвестиции, тренды, новые вызовы развития. Часть 2 | Цифровая терапия — фокус на результат, а не на технологию: инвестиции, тренды, новые вызовы развития. Часть 2 |
| 28.07.2021 | Digital therapy: focus on results, not technology: investments, trends, new development challenges. Part 2 | Digital therapy: focus on results, not technology: investments, trends, new development challenges. Part 2 |
| 05.06.2021 | Meet the startups taking part in the Health IT track for INVEST Precision Medicine Pitch Perfect | The INVEST Precision Medicine conference June 9-11, which will be held online, will explore a wide range of topics from advancing breakthrough therapies for rare disease and cancer, genetic testing, health equity, pediatric innovation and m... |
| 22.04.2021 | Current Health Lands $43M to Support Global Expansion of Remote Care Management Platform | What You Should Know:
– Today, Current Health, a Boston-based enterprise remote care management company announced that it has raised $43M in Series B financing. The Series B financing, which comes from top healthcare and pharma VCs, such as... |
| 26.03.2021 | StartUPDATES: New developments from healthcare startups | This week, Seven Bridges announced the launch of the GRAF™ Population Solution, a set of workflows, services and population-specific graph references to enable large-scale human population studies through more accurate read alignment and va... |
| 15.10.2020 | Ori Biotech Raises $30m in Series A financing to advance innovation in cell and gene therapy manufacturing | October 14 2020, London, UK and Woodcliff Lake, NJ – Ori Biotech Ltd (Ori), a leading innovator in cell and gene therapy (CGT) manufacturing, today announced the successful close of a $30 million Series A financing round, bringing the compa... |
| 15.10.2020 | Ori Biotech Raises $30m in Series A financing to advance innovation in cell and gene therapy manufacturing | Ori Biotech Raises $30m in Series A financing to advance innovation in cell and gene therapy manufacturing
15-10-2020
October 14 2020, London, UK and Woodcliff Lake, NJ – Ori Biotech Ltd (Ori), a leading innovator in cell and gene therapy (... |
| 15.10.2020 | Ori Biotech Lands $30M for Cell and Gene Therapy Manufacturing Platform | What You Should Know:
– Biotech startup Ori Biotech raises $30M in Series A funding to scale its cell and gene therapy (CGT) manufacturing platform.
– Ori Biotech helps pharmaceutical and biotech companies develop and manufacture cell and g... |
| - | Meet the startups taking part in the Health IT track for INVEST Precision Medicine Pitch Perfect | The INVEST Precision Medicine conference June 9-11, which will be held online, will explore a wide range of topics from advancing breakthrough therapies for rare disease and cancer, genetic testing, health equity, pediatric innovation and m... |
| - | StartUPDATES: New developments from healthcare startups | This week, Seven Bridges announced the launch of the GRAF™ Population Solution, a set of workflows, services and population-specific graph references to enable large-scale human population studies through more accurate read alignment and va... |
